Company news

Willfar Information Technology Co., Ltd. Class A (SSE:688100) news

Willfar Information Technology Co., Ltd. Class A news releases on 6ix. Latest, Sep 2, 2026: "Willfar Information Technology Co., Ltd."Announcement…

View Willfar Information Technology Co., Ltd. Class A →

Press releases & updates

"Willfar Information Technology Co., Ltd."Announcement on Voluntary Disclosure of Bid-Winning Contracts in August 2026

September 1, 2026

"Willfar Information Technology Co., Ltd."Announcement on Repurchase of Shares through Call Auction Reaching 2% and Progress of Share Repurchase

August 31, 2026

"Willfar Information Technology Co., Ltd."Announcement on Attending the 2026 Online Collective Reception Day for Investors of Listed Companies in Hunan Jurisdiction and Semi-annual Performance Briefing

August 25, 2026

"Willfar Information Technology Co., Ltd."Announcement on Shareholdings of Top 10 Shareholders and Top 10 Shareholders of Unrestricted Shares Concerning Share Repurchase

August 20, 2026

"Willfar Information Technology Co., Ltd."Announcement on the Initial Repurchase of Shares through Call Auction

August 19, 2026

"Willfar Information Technology Co., Ltd."Announcement on Resolutions of the 3rd Meeting of the 4th Board of Directors

August 17, 2026

"Willfar Information Technology Co., Ltd."Semi-annual Report for 2026

August 16, 2026

"Willfar Information Technology Co., Ltd."Announcement on Implementation Result of Share Repurchase

July 20, 2026

"Willfar Information Technology Co., Ltd."Announcement on Repurchase of 1% Shares through Call Auction and Progress of Share Repurchase

July 13, 2026

"Willfar Information Technology Co., Ltd."Announcement on Voluntary Disclosure of Contract Awards in June 2026

July 1, 2026

Announcement on Initially Repurchasing the Company's Shares through Call Auction

June 26, 2026

Everest Medicines and Hainan Herui have entered into a commercialization collaboration relating to Hainan Herui's budesonide enteric capsules, further enhancing patient access to the medication

June 24, 2026

Announcement on Shareholdings of Top 10 Shareholders and Top 10 Shareholders Not Subject to Sales Restrictions Concerning Share Repurchase

June 22, 2026

Announcement on Resolutions of the 1st Meeting of the 4th Board of Directors

June 18, 2026

Announcement on Convening Performance Briefing for 2025 and Q1 2026

June 17, 2026

Notice on Convening the 2nd Extraordinary General Meeting in 2026

June 2, 2026

Announcement on Voluntary Disclosure of Bid-winning Contracts in May 2026

June 1, 2026

Announcement on Resolutions of the 1st Extraordinary General Meeting in 2026

May 15, 2026

Announcement on Voluntary Disclosure of Bid-winning Contracts in April 2026

May 6, 2026

Announcement on Amending the "Articles of Association"

April 28, 2026

Indicative Announcement on Expiration of the 2nd Lock-up Period of Employee Stock Ownership Plan Phase I

April 7, 2026

Announcement on Implementation of Dividend Distribution for 2025

April 6, 2026

Announcement on Voluntary Disclosure of Bid-winning Contracts in March 2026

April 1, 2026

Announcement on Resolutions of the 2025 Annual General Meeting

March 20, 2026

Notice on Convening the Annual General Meeting in 2025

February 27, 2026

Announcement on Holding Investor Reception Day

January 12, 2026

Announcement on Voluntary Disclosure of Bid-winning Contracts in December 2025

January 6, 2026

Announcement on Voluntary Disclosure of Bid-winning Contracts in November 2025

December 2, 2025

Announcement on Convening the Q3 2025 Performance Briefing

November 16, 2025

Announcement on Resignation of Directors and Election of Employee Representative Director for the 3rd Board of Directors

November 7, 2025

Announcement on Voluntary Disclosure of Bid-winning Contracts in October 2025

November 3, 2025

Report for Q3 2025

October 22, 2025

Announcement on Voluntary Disclosure of Bid-winning Contracts in September 2025

October 8, 2025

Announcement on Attending 2025 Online Collective Reception Day for Investors of Listed Companies in Hunan Jurisdiction and Semi-annual Performance Briefing

September 11, 2025

Announcement on Implementation of Semi-annual Dividend Distribution for 2025

September 7, 2025

Announcement on Result of Shareholding Reduction by Shareholder with Over 5% Shares

September 4, 2025

Announcement on Voluntary Disclosure of Bid-winning Contracts in August 2025

September 1, 2025

Announcement on Attending the Semi-Annual Collective Performance Briefing of Listed Companies in Hunan Province on SSE STAR Market 2025

August 26, 2025

Announcement on Resolutions of the 1st Extraordinary General Meeting in 2025

August 18, 2025

Announcement on Release of Freezing of Shares Held by Shareholder with Over 5% Shares

August 1, 2025

Announcement on 2025 Interim Profit Distribution Plan

July 29, 2025

Announcement on Freezing of Shares Held by Shareholder with Over 5% Shares

July 18, 2025

Announcement on Progress in Repurchasing Shares through Call Auction

July 1, 2025

Announcement on Voluntary Disclosure of Obtaining the 25th China Patent Excellent Award

June 8, 2025

Announcement on Voluntary Disclosure of Bid-winning Contracts in May 2025

June 3, 2025

Announcement on Share Reduction Plan for Shareholders

May 13, 2025

Announcement on Convening the Q1 2025 Performance Briefing

May 11, 2025

Announcement on Voluntary Disclosure of Bid-winning Contracts in April 2025

May 6, 2025

Report for Q1 2025

April 25, 2025

Announcement on Adjusting Upper Limit of Shares Repurchase Price after Implementing Annual Dividend Distribution for 2024

April 16, 2025

Older →